載入...
Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD
The Coronavirus 2019 (COVID-19) pandemic has posed challenges in the routine care of patients with inflammatory bowel disease. One of the key challenges needing addressing is the quantification of the risks of immunosuppressive and biologic therapies in IBD patients during the pandemic. The similari...
Na minha lista:
| 發表在: | J Crohns Colitis |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7314090/ https://ncbi.nlm.nih.gov/pubmed/32520312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjaa120 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|